ADK.V - DIAGNOS Inc.
| Previous Close | 0.3350 |
| Open | 0.3300 |
| Bid | 0.3300 x 0 |
| Ask | 0.3350 x 0 |
| Day's Range | 0.3250 - 0.3300 |
| 52 Week Range | 0.1300 - 0.4500 |
| Volume | |
| Avg. Volume | 111,547 |
| Market Cap | 22.926M |
| Beta (5Y Monthly) | -0.09 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0400 |
| Earnings Date | Jul 11, 2023 - Jul 17, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.00 |
GlobeNewswireDIAGNOS Announces Closing of Private Placement and Exercise of Stock Warrants
BROSSARD, Quebec, May 18, 2023 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a Canadian corporation active in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the closing, today, of a non-brokered private placement (“Private Placement”) of unsecured convertible debentures (each a “Debenture”) and stock warrants (each a “Warrant”) for gross proceeds of $865,000.
GlobeNewswireDIAGNOS and IRIS, The Visual Group strengthen partnership with the launch of “IRIS-ai powered by DIAGNOS”
IRIS-ai powered by DIAGNOS IRIS-ai powered by DIAGNOS BROSSARD, Quebec, May 17, 2023 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce the launch of “IRIS-ai powered by DIAGNOS” by IRIS, The Visual Group, in partnership with DIAGNOS. For over two years, IRIS and DIAGNOS have joined forces
GlobeNewswireDIAGNOS and ÉTS Unveil a Method to Adapt Deep Learning Algorithms According to the Diversity of Contexts
Diagnos - Domain Adaptation Method Diagnos - Domain Adaptation Method BROSSARD, Quebec, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) is one of the leaders in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI). DIAGNOS and École de Technologie Supérieure (ÉTS), a world-renowned technical university, are proud to announce the unveiling of a method for adapt
GlobeNewswireDIAGNOS and ETS to Present Ground-breaking Research on Mass Screening for Macular Edema at ARVO 2023
Section of the eye Section of the eye BROSSARD, Quebec, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) is a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI). DIAGNOS and École de Technologie Supérieure (ÉTS), a world-renowned technical university, are proud to announce that they will be presenting the results of their ground-breaking research on
GlobeNewswireDIAGNOS Announces Grant of Stock Options
BROSSARD, Quebec, Feb. 10, 2023 (GLOBE NEWSWIRE) -- February 10, 2023 – Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the grant of an aggregate number of 1,275,000 stock options to its officers, employees, consultants and directors. Stock options vest at 50% per year, commencing with the first anniversary of the grant. Th
GlobeNewswireDIAGNOS Gets the Green Light for the Use of its Diabetic Retinopathy Screening Technology in Quebec Hospitals
DIagnos Gets Approval for Quebec Hospitals DIagnos Gets Approval for Quebec Hospitals BROSSARD, Quebec, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce that the Quebec government has given the green light to Diagnos' Artificial Intelligence (AI) technology to screen and as
- GlobeNewswire
DIAGNOS Announces Closing of Private Placement
BROSSARD, Quebec, Jan. 13, 2023 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the closing, today, of a non-brokered private placement (“Private Placement”) of 5 units (each a “Unit”) issued at a price of $50,000 per Unit for gross proceeds of $250,000. For the period of November 25, 2022 to this date,
- GlobeNewswire
DIAGNOS Provides Additional Information to the Closing of Private Placement
BROSSARD, Quebec, Dec. 15, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces that in connection with the closing of the private placement announced on December 12, 2022, the Corporation paid a cash commission of $9,000 to one qualified person (“Finder”) and issued 40,909 finder’s warrants to the Finde
GlobeNewswireDIAGNOS Enters the Retinal Diagnostics Market With its New 3D Image Analysis Technology
Retina Scanning Retina Scanning BROSSARD, Quebec, Oct. 27, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is proud to announce it is entering the fast-growing retinal diagnostics market, armed with its new 3D image analysis technology. DIAGNOS is pushing the boundaries of the practice with a deep learni
GlobeNewswireDIAGNOS Receives Regulatory Approval from the Costa Rica Health Agency for its Artificial Intelligence Enabled Pathology Detection Systems
BROSSARD, Quebec, Aug. 18, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is proud to announce the receipt of approval from the Costa Rican regulatory agency (Ministerio de Salud) for its Artificial Intelligence enabled Pathology Detection Systems. DIAGNOS’ platform has been approved for having complied
- GlobeNewswire
DIAGNOS Continues Expansion in Canada with Kick-off of Services in Endocrinology Clinics with Distribution Partner Labtician Ophthalmics
BROSSARD, Quebec, July 27, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is proud to continue its expansion in Canada with the kick-off of its services in endocrinology clinics with distribution partner Labtician Ophthalmics. DIAGNOS is announcing the kick-off by Labtician Ophthalmics (“Labtician”) of
- GlobeNewswire
DIAGNOS Announces the Start of the Deployment of its Pathology Detection Systems in the Retail Clinics of Farmacias Benavides, a Member of Walgreens Boots Alliance
BROSSARD, Quebec, June 23, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce the start of the deployment of its pathology detection systems in the retail clinics of Farmacias Benavides, a member of Walgreens Boots Alliance. “Following the signing of the agreement between DIAGNOS and
- GlobeNewswire
DIAGNOS Announces the Deployment of its Age-Related Macular Degeneration Detection Application Into the Optometry Clinics of IRIS, The Visual Group
BROSSARD, Quebec, June 07, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce the deployment of its Age-Related Macular Degeneration detection application into the optometry clinics of IRIS The Visual Group. It is with great pleasure that DIAGNOS is announcing the deployment of its Ag